# K012994: Wizair DVT

- Pathway: 510(k) (Traditional)
- Applicant: Medical Compression Systems (Dbn), Ltd.
- Decided: Mar 27, 2002 after 202 days
- Product code: JOW (Sleeve, Limb, Compressible)
- Device class: 2
- Regulation: 21 CFR 870.5800
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
36 later devices descend from it; 6 cite it directly.
0 of 37 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names no predicate by number.

## Most influential descendants
- K060146: Activecare ++ System (2006), 30 descendants of its own
- K062818: Flexitouch System (2006), 10 descendants of its own
- K120972: Flexitouch System (2012), 9 descendants of its own
- K110159: Activecare SFT (2011), 9 descendants of its own
- K153311: Flexitouch System (2016), 8 descendants of its own

## Indications for use
The WizAir DVT™ is a prescriptive device that induces Continuous Enhanced Circulation Therapy of the lower limbs. The WizAir DVT™ is intended for use in: Preventing Deep Vein Thrombosis (DVT). Enhancing blood circulation. Diminishing post-operative pain and swelling. Reducing wound-healing time. Treatment and assistance in healing: stasis dermatitis; venous stasis ulcers; arterial and diabetic leg ulcers. Treatment of chronic venous insufficiency. Reducing edema.

Source page: https://510kreport.com/device/K012994
Methodology: https://510kreport.com/methodology